Loading...
IOVA IOVANCE BIOTHERAPEUTICS INC Operational Disruptions 8-K Filing
Back
VNC
V
IOVANCE BIOTHERAPEUTICS INC
(IOVA)
Follow
FY2024 8 K
View More
Back
VNC
V
IOVANCE BIOTHERAPEUTICS INC
(IOVA)
Follow
FY2024 8 K
Filing:
8 K
Published on:
23 May '24
Management Change
10 Feb '25
Office Relocation
21 Nov '24
Corporate Presentation Update
7 Nov '24
Financial Results
7 Nov '24
Presentation Update
9 Aug '24
Earnings Reports
8 Aug '24
Submission of Marketing Aut...
28 Jun '24
Annual Meeting of Stockholders
11 Jun '24
Presentation Update
3 Jun '24
Clinical Data Announcement
23 May '24
Financial Results Announcement
9 May '24
Settlement of Stockholder D...
3 Apr '24
Retirement and Nomination
29 Mar '24
Press Release
4 Mar '24
Corporate Presentation Update
29 Feb '24
Financial Results Announcement
28 Feb '24
Sale of Common Stock
22 Feb '24
Underwriting Agreement
20 Feb '24
Financial Results and FDA A...
20 Feb '24
Presentation Update
25 Jan '24
Presentation Update
8 Jan '24
Press Release
27 Dec '23
Earnings Reports
7 Nov '23
FDA Update on Lifileucel Ta...
15 Sep '23
Unauthorized Posting of Pre...
18 Aug '23
Earnings Release
8 Aug '23
Open Market Sale Agreement
16 Jun '23
Annual Meeting of Stockholders
6 Jun '23
FDA Accepts Biologics Licen...
26 May '23
Acquisition of Worldwide Ri...
18 May '23
Earnings Report
9 May '23
Appointment of Director
24 Apr '23
FDA Submission Completed
27 Mar '23
Disclosure
10 Mar '23
Earnings Release
28 Feb '23
Acquisition of Worldwide Ri...
23 Jan '23
Corporate Presentation Update
10 Jan '23
External Links:
SEC
AI Assistant
Close
IOVANCE BIOTHERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.